[Interpretation of the 2021 American Academy of Allergy, Asthma and Immunology expert consensus on the treatment of postinfectious olfactory dysfunction].
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi
; 37(2): 81-86, 2023 Feb.
Article
in Chinese
| MEDLINE | ID: covidwho-20236516
ABSTRACT
Respiratory tract viruses are the second leading cause of olfactory dysfunction. Between 2019 to 2022, the world has been plagued by the problem of olfaction caused by the COVID-19. As we learn more about the impact of severe acute respiratory syndrome coronavirus 2ï¼SARS-CoV-2ï¼, with the recognition that olfactory dysfunction is a key symptom of this disease process, there is a greater need than ever for evidence-based management of postinfectious olfactory dysfunctionï¼PIODï¼. The Clinical Olfactory Working Group has proposed theconsensus on the roles of PIOD. This paper is the detailed interpretation of the consensus.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Asthma
/
COVID-19
/
Hypersensitivity
/
Olfaction Disorders
Type of study:
Prognostic study
Topics:
Long Covid
Limits:
Humans
Country/Region as subject:
North America
Language:
Chinese
Journal:
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi
Year:
2023
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS